BLOSSOMHILL THERAPEUTICS, INC. <BLSM.O>: H.C. WAINWRIGHT INITIATES COVERAGE WITH BUY RATING AND TARGET PRICE $35

Reuters2026/09/01 10:09

By:Reuters

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

AI Is Taking Power, Not Bitcoin Place, Says ViaBTC CEO

CoinEdition•2026/09/01 11:42

BTC Buying Buzz Returns With Saylor Back in Focus as IceBull Starts Much Earlier in the Next 1000x Crypto Race

Coinomedia•2026/09/01 11:39

ANNEXON, INC. : JP MORGAN RAISES TARGET PRICE TO $14 FROM $10

Reuters•2026/09/01 11:33

-- Earnings Flash (ROOF.V) Northstar Clean Technologies Inc. Reports Q2 Revenue C$209K

MT newswire•2026/09/01 11:33